Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The scorpion venom neurotoxins from Leiurus quinquestriatus, Androctonus amoreuxi, and Androctonus australis hector are a group of highly potent peptides that disrupt physiological functions by modulating ion channels (UniProt: P01481, P01484). These toxins primarily target voltage-gated sodium channels (Nav) and potassium channels (K+), leading to prolonged depolarization of excitable cells and a massive release of neurotransmitters (PMID: 15530634). Clinically, this results in a sympathetic storm or cholinergic crisis, characterized by cardiovascular instability, respiratory distress, and neuromuscular dysfunction (StatPearls: Scorpion Toxicity). In the pharmaceutical context, these neurotoxins are the primary targets for polyvalent antivenom therapies, which employ purified immunoglobulins or F(ab')2 fragments to neutralize the toxins before they can bind to their physiological receptors (PMID: 11543984). While these toxins are the causative agents of severe envenomation, they also serve as critical tools in neurobiology for mapping ion channel structures and functions. Furthermore, specific toxins like chlorotoxin from L. quinquestriatus have been investigated for their potential in targeted cancer imaging and therapy due to their ability to bind specifically to certain tumor cells (PMID: 9563312).
Antivenoms function by providing passive immunity through the administration of specific antibodies or antibody fragments (such as F(ab')2) that bind to and neutralize circulating venom neurotoxins (StatPearls: Scorpion Toxicity). This sequestration prevents the toxins from reaching and binding to their physiological targets, primarily voltage-gated sodium and potassium channels, thereby halting the progression of neurotoxic and autonomic symptoms (PMID: 11543984).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scorpion venom neurotoxins (Leiurus quinquestriatus, Androctonus amoreuxi, Androctonus australis hector).